Corporate Performance
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Track global pharma corporate performance, M&A, earnings, and strategic shifts. Gain critical intelligence for investment and business development decisions.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Corporate Performance hub for FDA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Eli Lilly issues data sharing ultimatum to 340B hospitals
Why US-manufactured pharmaceutical packaging equipment matters
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.